Have a personal or library account? Click to login
Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells Cover

Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells

Acta Pharmaceutica
Volume 71 (2021): Issue 2 (June 2021)
By: Shuaishuai Huang,  Gulimire Tuergong,  Hangjie Zhu,  Xue Wang,  Guobin Weng and  Yu Ren  
Open Access
|Nov 2020

Authors

Shuaishuai Huang

Laboratory of Renal Carcinoma, China
Zhejiang Key Laboratory of Pathophysiology, Ningbo University, China

Gulimire Tuergong

Zhejiang Key Laboratory of Pathophysiology, Ningbo University, China

Hangjie Zhu

Zhejiang Key Laboratory of Pathophysiology, Ningbo University, China

Xue Wang

Laboratory of Renal Carcinoma, China
Zhejiang Key Laboratory of Pathophysiology, Ningbo University, China

Guobin Weng

ddwgbin@aliyun.com

Laboratory of Renal Carcinoma, China

Yu Ren

nbrenyu@163.com

Laboratory of Renal Carcinoma, China
DOI: https://doi.org/10.2478/acph-2021-0012 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 267 - 278
Accepted on: Apr 15, 2020
Published on: Nov 4, 2020
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
norcantharidin,
renal cancer cells,
ERK,
JNK,
p38 MAPK,
apoptosis,
cell cycle arrest
Related subjects:
Pharmacy,
Pharmacy, other

© 2020 Shuaishuai Huang, Gulimire Tuergong, Hangjie Zhu, Xue Wang, Guobin Weng, Yu Ren, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 71 (2021): Issue 2 (June 2021)Next article